Medicine news

Turakhia joins iRhythm for planned leave | News from the Department of Medicine

Mintu Turakhia MD, MASprofessor of medicine (cardiovascular medicine), will take a planned leave of absence from Stanford to join iRhythm Technologies, Inc. as the new Chief Medical Officer and Chief Scientific Officer.

One of the earliest and most successful companies spun off from the Stanford Biodesign program, iRhythm is perhaps best known for its heart monitoring device invented here. The new leadership role will allow Turakhia to combine her clinical and scientific interests in cardiac electrophysiology, pragmatic clinical trials, digital health, wearables and artificial intelligence and pursue her passion for transforming cardiovascular care.

The projects, programs, and grants that Turakhia led at Stanford will continue to thrive and support faculty, interns, and staff. the Digital Health Center (CDH) in the Department of Medicine flourished under his leadership, securing an extensive funding portfolio, basic research publications, public-private partnerships, and an innovative health technology postdoctoral fellowship program. Clark Seninger MBA will continue to serve as its executive director and work with a CDH leadership team that includes Dr. Fatima Rodriguez, Dr. Euan Ashley, Dr. Paul Wang, Dr. Alex Sandhu, Dr. Raj Dash and others.

Turakhia had an extraordinary impact at Stanford, not only in the areas of science, teaching, and patient care, but also in building great, enduring programs. He has mentored over 50 trainees, many of whom are still in the Department of Medicine. While on leave, he will continue to serve in volunteer teaching and mentoring roles and he will also pursue limited clinical practice at VA Palo Alto.

Department of Medicine Chairman Bob Harrington expressed his full support for this next step in Turakhia’s career, “I am thrilled that Mintu has this incredible opportunity at iRhythm to apply his extensive patient care experience and leadership. unparalleled in digital health and cardiac rhythm care at Stanford to the critical and ever-changing landscape of cardiovascular medicine. We look forward to his return.”

Read the full press release